Wendy G Nieto

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Dendritic Cells

Chronic Lymphocytic Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ignacio Criado, Wendy G Nieto, Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Cristina Teodosio, Quentin Lecrevisse, Antonio Lopez, Alfonso Romero, Julia Almeida, Alberto Orfao, null The Primary Health Care Group Of Salamanca For The Study Of Mbl
Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects. Cancers 15 (1) (2022)
Ignacio Criado, Wendy G Nieto, Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Cristina Teodosio, Quentin Lecrevisse, Antonio Lopez, Alfonso Romero, Julia Almeida, Alberto Orfao, null The Primary Health Care Group Of Salamanca For The Study Of Mbl
Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects. Cancers 15 (1) (2022)
Ignacio Criado, Wendy G Nieto, Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Cristina Teodosio, Quentin Lecrevisse, Antonio Lopez, Alfonso Romero, Julia Almeida, Alberto Orfao, null The Primary Health Care Group Of Salamanca For The Study Of Mbl
Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects. Cancers 15 (1) (2022)
Ignacio Criado, Wendy G Nieto, Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Cristina Teodosio, Quentin Lecrevisse, Antonio Lopez, Alfonso Romero, Julia Almeida, Alberto Orfao, null The Primary Health Care Group Of Salamanca For The Study Of Mbl
Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects. Cancers 15 (1) (2022)